Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Prospective Evaluation of Biliary Tissue Sampling with ERCP
Prospective evaluation of biliary tissue sampling using ERCP is currently enrolling by invitation at Mayo Clinic.
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma [NA]
A clinical trial is recruiting to assess GEMOX combined with targeted therapy and immunotherapy for advanced cholangiocarcinoma, sponsored b…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Robotically Assisted Surgery For Perihilar Cholangiocarcinoma: A Prospective Study
Prospective study evaluating robotically assisted surgery for perihilar cholangiocarcinoma is currently recruiting. Sponsored by Azienda Osp…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.
This clinical trial update describes a prospective multicenter study evaluating an AI-assisted ROSE system for EUS-FNA samples to diagnose m…
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Spanish Registry of Digestive Tumours RETUD
This entry notes the RETUD Spanish registry for digestive tumours is currently recruiting, sponsored by the Spanish Cooperative Group for th…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer [Phase 2]
Phase II trial evaluates a combination of surufatinib with gemcitabine, cisplatin, and durvalumab or pembrolizumab for advanced biliary trac…
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: Evaluating a Community-Based Behaviour Change Communication Model to Prevent Cholangiocarcinoma in Khon Kaen, Thailand [NA]
A McMaster University-sponsored clinical trial in Khon Kaen, Thailand is evaluating a community-based behaviour-change communication model t…
-
CLINICAL_TRIALS research · 2024-11-07Clinical Trial Update: Neo-adjuvant Chemo and Immunotherapy in the Pre-operAtive Treatment of Locally Advanced CholangIOcarciNoma [Phase 2]
A Phase 2 study evaluating neoadjuvant chemotherapy with immunotherapy before surgery for locally advanced cholangiocarcinoma is currently r…
-
CLINICAL_TRIALS research · 2024-11-04Clinical Trial Update: Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction [Phase 3]
A Phase 3 clinical trial comparing primary percutaneous stenting above the ampulla to endoscopic drainage for unresectable malignant hilar b…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography
This entry describes the Spanish Registry of Quality Indicators and Adverse Events for Endoscopic Retrograde Cholangiopancreatography (ERCP)…
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: A Novel Serological Risk Model for Early Non-invasive Diagnosis of Cholangiocarcinoma
A clinical trial update describing a novel serological risk model for early, non-invasive diagnosis of cholangiocarcinoma, currently not yet…
-
CLINICAL_TRIALS research · 2024-10-10Clinical Trial Update: Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma [NA]
A clinical trial is investigating liver transplantation for patients with stable, advanced intrahepatic cholangiocarcinoma. Enrollment is by…
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Safety and Anti-Tumor Activity of TYRA-200 in Advanced Cholangiocarcinoma With Activating FGFR2 Gene Alterations [Phase 1]
TYRA-200 is being studied in a Phase 1 trial to assess safety and anti-tumor activity in advanced cholangiocarcinoma with FGFR2 alterations.…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Gemcitabine/Cisplatin/Nab-Paclitaxel and Rilvegostomig in Resectable iCCA [Phase 2]
Phase 2 trial update evaluating gemcitabine/cisplatin/nab-paclitaxel with rilvegostomig in resectable cholangiocarcinoma; currently not yet …
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Evaluation of Combined Modality Protons and Hepatic Transplantation for Hilar Cholangiocarcinoma [NA]
A clinical trial evaluating proton therapy combined with hepatic transplantation for hilar cholangiocarcinoma, currently not recruiting.
-
CLINICAL_TRIALS research · 2024-08-09Clinical Trial Update: TCF-001 TRACK (Target Rare Cancer Knowledge) Study [NA]
Clinical trial update for TCF-001 TRACK study (Target Rare Cancer Knowledge) is currently recruiting. The study targets cholangiocarcinoma a…
-
CLINICAL_TRIALS research · 2024-08-02Clinical Trial Update: Impact of Preoperative Endoscopic Ultrasound-guided Fine-needle Aspiration in Cholangiocarcinoma Patients
Clinical trial update describing a study assessing the impact of preoperative endoscopic ultrasound-guided fine-needle aspiration in cholang…
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating the combination of olaparib and durvalumab in IDH-mutated solid tumors, including glioma and cholangiocarc…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer [Phase 2]
Phase II clinical trial evaluating SHR-A1811 in patients with HER2-expressing or HER2-amplified biliary tract cancer; recruitment is ongoing…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Phase 2 Study: OBI-833/OBI-821 Maintenance for Globo H+ Advanced Biliary Tract Cancer After Gemcitabine/Cisplatin [Phase 1]
A Phase 2 maintenance trial of OBI-833 and OBI-821 for Globo H-positive advanced biliary tract cancer after gemcitabine/cisplatin is not yet…
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors [NA]
This clinical trial assesses the combination of transarterial chemoembolization (TACE) with immune checkpoint inhibitors for non-resectable …
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma [Phase 3]
A Phase 3 clinical trial evaluating tinengotinib versus physician's choice for FGFR-altered cholangiocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
A clinical trial is enrolling a cohort of patients with hepatocellular carcinoma or cholangiocarcinoma.
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma [NA]
This NOT_YET_RECRUITING clinical trial is evaluating a three-drug combination of irinotecan liposome, capecitabine, and lenvatinib in biliar…
-
CLINICAL_TRIALS research · 2024-05-30Clinical Trial Update: Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement [Phase 2]
Clinical trial update on a Phase 2 study of pemigatinib for advanced/metastatic or surgically unresectable cholangiocarcinoma, including FGF…